瑞巴派特灌肠治疗溃疡性结肠炎疗效观察  

The observation on the effect of rebamipide in treatment of the ulcerative colitis

作　　者：郭玉琳[1] 饶敏[1] 杨卓[1] 杨文颖[1] 

机构地区：[1]吉林省人民医院消化内科,130021

出　　处：《国际消化病杂志》2008年第6期513-514,共2页International Journal of Digestive Diseases

摘　　要：目的观察瑞巴派特联合左氧氟沙星、地塞米松保留灌肠对远端溃疡性结肠炎(UC)的疗效。方法选择150例患者随机分为治疗组和对照组,治疗组应用瑞巴派特联合左氧氟沙星、地塞米松保留灌肠治疗,对照组应用左氧氟沙星、地塞米松灌肠治疗。结果治疗组显效率44,总有效率84,明显高于对照组(显效率30,总有效率66),(P<0.05)。结论瑞巴派特联合左氧氟沙星、地塞米松保留灌肠治疗远端UC疗效满意,值得临床推广应用。Objective To observe the effect of using rebamipide,dexamethasone and levofloxacin in the treatment of the ulcerative colitis. Method 150 patients were randomly divided into two groups, therapy group and control group. In therapy group we used rebamipide,dexamethasone and levofloxacin to treat the ulcerative colitis, and in control group we used dexamethasone and levofloxacin to treat the ulcerative colitis. Result In therapy group the excellence rate was 44%, the total effective rate was 840/00. In control group the excellence rate was 300/00, the total effective rate was 66% in control group. We found that the total effective rate in therapy group was more excellent than that in control group（P〈0.05）. Conelusion The effect of using rebamipide,dexamethasone and levofloxacin in the treatment of the ulcerative colitis is satisfactory.

关 键 词：瑞巴派特 左氧氟沙星 地塞米松 保留灌肠 

分 类 号：R574.6[医药卫生—消化系统]